Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain

OBJECTIVE: To evaluate the cost-effectiveness of Budesonide/Glycopyrronium/Formoterol (BUD/GLY/FOR) versus LAMA/LABA and ICS/LABA, respectively, in patients with moderate to severe COPD, from the Spanish National Healthcare System (NHS) perspective. METHODS: A lifetime Markov model with monthly cycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Trigueros, Juan Antonio, Garin, Noé, Baloira, Adolfo, Aceituno, Susana, Calvo, Ana, Prades, Miriam, Touron, Carolina, Martínez, Anisia, Torres, Covadonga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675425/
https://www.ncbi.nlm.nih.gov/pubmed/36411773
http://dx.doi.org/10.2147/COPD.S384591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675425/
https://www.ncbi.nlm.nih.gov/pubmed/36411773
http://dx.doi.org/10.2147/COPD.S384591

Ejemplares similares